We are live on ! Find out more
ONCE

Spark Therapeutics, Inc. Common Stock
ONCE

Delisted

ONCE was delisted on the 16th of December, 2019.

Back to rankings

160 hedge funds and large institutions have $1.92B invested in Spark Therapeutics, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 61 increasing their positions, 33 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

90% more call options, than puts

Call options by funds: $33.3M | Put options by funds: $17.5M

85% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 33

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

6% less first-time investments, than exits

New positions opened: 44 | Existing positions closed: 47

2% less funds holding

Funds holding: 163 → 160 (-3)

39% less capital invested

Capital invested by funds: $3.15B → $1.92B (-$1.23B)

Holders
160
Holders Change
-3
Holders Change %
-1.84%
% of All Funds
3.63%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
44
Increased
61
Reduced
33
Closed
47
Calls
$33.3M
Puts
$17.5M
Net Calls
+$15.8M
Net Calls Change
+$18.4M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$161M
2
GGHC
Gilder Gagnon Howe & Co
New York
+$39.4M
3
GPP
Great Point Partners
Connecticut
+$29.5M
4
JP Morgan Chase
JP Morgan Chase
New York
+$28.1M
5
RFS
Rockefeller Financial Services
New York
+$25.3M

Top Sellers

Rank Fund Capital Flow
1
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$55.1M
2
Deutsche Bank
Deutsche Bank
Germany
-$54.9M
3
O
OrbiMed
New York
-$38.3M
4
LCM
Laurion Capital Management
New York
-$34.7M
5
Jennison Associates
Jennison Associates
New York
-$27.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
MCM
176
Moore Capital Management
New York
– -$3.12M -35,000 Closed
EI
177
EAM Investors
California
– -$2.45M -27,445 Closed
JG
178
Jefferies Group
New York
– -$2.33M -26,100 Closed
TCM
179
Timpani Capital Management
Wisconsin
– -$2.29M -25,697 Closed
ACM
180
Atika Capital Management
New York
– -$2.05M -23,000 Closed
Credit Agricole
181
Credit Agricole
France
– -$1.91M -21,400 Closed
NFA
182
Nationwide Fund Advisors
Ohio
– -$1.88M -21,028 Closed
Point72 Asset Management
183
Point72 Asset Management
Connecticut
– -$1.77M -19,802 Closed
Voloridge Investment Management
184
Voloridge Investment Management
Florida
– -$1.64M -18,364 Closed
SSA
185
Schonfeld Strategic Advisors
New York
– -$1.49M -16,707 Closed
PPA
186
Parametric Portfolio Associates
Washington
– -$1.45M -16,226 Closed
SEC
187
Seven Eight Capital
New York
– -$1.24M -13,900 Closed
CSS
188
Cubist Systematic Strategies
Connecticut
– -$766K -8,588 Closed
Neuberger Berman Group
189
Neuberger Berman Group
New York
– -$672K -7,541 Closed
BCM
190
Bayesian Capital Management
New York
– -$574K -6,442 Closed
EIM
191
Essex Investment Management
Massachusetts
– -$472K -5,298 Closed
CLCM
192
Crawford Lake Capital Management
New Jersey
– -$430K -4,825 Closed
BAM
193
Belpointe Asset Management
Nevada
– -$403K -4,520 Closed
Squarepoint
194
Squarepoint
New York
– -$371K -4,161 Closed
RJA
195
Raymond James & Associates
Florida
– -$341K -3,820 Closed
AB
196
Amalgamated Bank
New York
– -$303K -3,397 Closed
TRCT
197
Tower Research Capital (TRC)
New York
– -$264K -2,962 Closed
Commonwealth Equity Services
198
Commonwealth Equity Services
Massachusetts
– -$257K -2,884 Closed
Prudential Financial
199
Prudential Financial
New Jersey
– -$239K -2,675 Closed
PCM
200
Prelude Capital Management
New York
– -$198K -2,220 Closed
5 6 7
8
9

ONCE Hedge Fund Activity: Q4 2017 in Review

160 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Spark Therapeutics, Inc. Common Stock (ONCE) for Q4 2017, worth a combined $1.92B — down 39% from $3.15B a quarter earlier.

Sellers outnumbered buyers: 47 funds closed out of ONCE and 44 opened new positions — a net loss of 3 holders — while 33 trimmed existing stakes and 61 added.

The largest buyer was Wellington Management Group, adding an estimated $161M. The largest seller was Lord, Abbett & Co, cutting an estimated $55.1M.

  • 160 institutional investors held Spark Therapeutics, Inc. Common Stock (ONCE) as of Q4 2017, down from 163 in Q3 2017.
  • Funds reported $1.92B of Spark Therapeutics, Inc. Common Stock stock for Q4 2017, down 39% quarter-over-quarter.
  • 44 funds opened new Spark Therapeutics, Inc. Common Stock positions in Q4 2017 and 47 closed out, a net change of -3 holders.
  • The largest Spark Therapeutics, Inc. Common Stock buyer in Q4 2017 was Wellington Management Group, an estimated $161M added.
  • The largest Spark Therapeutics, Inc. Common Stock seller in Q4 2017 was Lord, Abbett & Co, an estimated $55.1M sold.

Based on aggregated 13F filings for Q4 2017.